This list is an analysis based on recent market events. It's not an investment recommendation.
About
Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
The current price of 373110.KQ is ₩965 KRW — it has decreased by -2.53% in the past 24 hours. Watch Xcell Therapeutics stock price performance more closely on the chart.
What is Xcell Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Xcell Therapeutics stocks are traded under the ticker 373110.KQ.
Is Xcell Therapeutics stock price growing?▼
373110.KQ stock has fallen by -6.44% compared to the previous week, the month change is a -2.01% fall, over the last year Xcell Therapeutics has showed a -55.67% decrease.
How many employees does Xcell Therapeutics have?▼
As of November 4, 2026, the company has 65 employees.
In which sector is Xcell Therapeutics located?▼
Xcell Therapeutics operates in the Health & Wellness sector.
When did Xcell Therapeutics complete a stock split?▼
Xcell Therapeutics has not had any recent stock splits.
Where is Xcell Therapeutics headquartered?▼
Xcell Therapeutics is headquartered in Seoul, South Korea.